The frequency, hematological characteristics, and end-of induction residual disease in B-acute lymphoblastic leukemia with BCR-ABL1-like chimeric gene fusions in a high-risk cohort from India

Click to increase image sizeClick to decrease image size

Acknowledgments

Authors acknowledge the valuable support of Prof. Reena Das, Prof Jasmina Ahuwalia, Dr. Shano Naseem, Dr Narender Kumar, Dr Nabhajit Mallik, Mrs Parveen Bose, Mr. Jogeshwar Binota and Mrs. Minakshi Gupta of Department of Hematology and other faculty members of the Department of Adult Hematology.

Author contributions

PvS and SS wrote the manuscript. SR performed flow cytometry and FISH testing and collected the data. HV analyzed the flow cytometry data. MUSS performed flow-cytometry testing and reviewed the manuscript. PsS, NV, RJ, AK, DB, AT, ARK and PM provided patients’ data, reviewed, and gave final approval for the manuscript. SS designed the study, obtained the funding, analyzed the data, critically revised, and reviewed the manuscript. All authors agree to the content of the manuscript and its interpretations.

Ethics approval

Institutional ethics committee approval was obtained, and the research was carried out according to the Institutional ethics guidelines. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.

Informed consent

Written informed consent was obtained from all patients in this study.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

Data shall be shared on request to the corresponding author.

Additional information

Funding

The work was supported by an extramural research grant (ECR/2017/000293) from the Science and Engineering Research Board (SERB), Government of India awarded to Sreejesh Sreedharanunni and National Cancer Grid to Amita Trehan.